MIRTAZAPINE BLUEFISH 15 mg, orodispersible tablet 30 tablets
Active ingredients: Mirtazapine
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MIRTAZAPINE BLUEFISH 15 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polyamide aluminium PVC papier polyester de 30 comprimé(s)
- Marketing authorisation holder
- BLUEFISH PHARMACEUTICALS (SUEDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Jun 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60809985CIP73876017CIP133400938760170Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MIRTAZAPINEcomprimé | 15 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.